Neoadjuvant Pembrolizumab

Clinical trial NCT02818920 · COMPLETED

Trial details

NCT number: NCT02818920
Sponsor: Neal Ready MD PhD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Carcinoma

Start date: 2017-01-01
Primary completion: 2019-03-19
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.